HealthVerity

Overview

HealthVerity is a privacy-preserving real-world data and commercial analytics platform for life sciences teams that need to find, license, link, and analyze de-identified healthcare data. Its core role is not hub operations, field deployment, or patient-services outsourcing; it is the infrastructure layer for connecting claims, EHR, labs, notes, imaging, commercial, specialty, and consumer-data signals without exposing identifiable patient information.

The buyer-relevant question is whether a manufacturer needs a neutral marketplace and identity layer, or whether a single-source analytics vendor is enough. HealthVerity is most useful when evidence, access, clinical development, commercial analytics, audience activation, or patient-finding teams need multi-source patient journeys that can move from source discovery into governed analysis and downstream activation.

Platform Capability Model

The framework below standardizes how Rx Almanac evaluates data-technology-platforms capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, HealthVerity is evaluated as a data-technology platform for life sciences teams that need privacy-preserving access to linked real-world data and commercial analytics.

Capability	Buyer should compare	HealthVerity readout
Data aggregation and interoperability	Claims, EHR, CRM, pharmacy, provider, payer, and FHIR/API connectivity with normalization and identity resolution.	Major data foundation. HealthVerity Marketplace is built for source discovery, licensing, and linked delivery; HealthVerity reports 75+ sources, 340M+ de-identified patients, and 200B+ transactions.
Commercial analytics and patient finding	Targeting, segmentation, patient finding, provider analytics, referral leakage, and opportunity sizing.	Expanding commercial lane. Symphony Health adds prescription-market analytics; Claritas Rx adds specialty journey context; HealthVerity Audiences adds activation-oriented segment building.
Workflow automation and CRM integration	Case workflows, field workflows, CRM, task automation, document handling, and operational queue management.	Not the main buying reason for HealthVerity; validate only if the SOW includes workflow automation or CRM integration.
Provider, payer, and pharmacy network connectivity	Network reach across HCPs, payers, pharmacies, labs, health systems, and transaction endpoints.	Partner-mediated reach. Public examples include PPD, Recursion, Arcadia, OneMedNet, Premier, Claritas Rx, and Medeloop.
AI, NLP, and unstructured data extraction	Conversation intelligence, document AI, NLP extraction, predictive models, and model monitoring.	Emerging evidence workflow. taXonomy Pathways and Medeloop-powered eXOs broaden HealthVerity beyond claims-only analysis; validate method transparency and review controls.
Security, compliance, and governance	HIPAA, SOC2, data-use controls, auditability, consent, privacy, and regulated-workflow safeguards.	Major governance control. HVID and privacy-preserving linkage are central to the platform; buyers should still validate controls for each use case.
Reporting, dashboards, and data delivery	Dashboards, exports, APIs, scheduled reporting, and downstream feeds to analytics or operating teams.	Tie delivery to workflow. Marketplace delivery, eXOs outputs, and Audiences activation have different handoff points; confirm exports, code, dashboards, and partner activation paths.

Buyer Fit

• Best-fit motion: Select HealthVerity when the manufacturer needs a privacy-preserving data marketplace, patient-linkage infrastructure, or connected clinical-plus-commercial data environment.
• Best-fit teams: HEOR, RWE, medical affairs analytics, clinical development, market access analytics, commercial operations, media analytics, and data science.
• Therapy and product fit: Broadest fit for specialty, rare disease, biologics, oncology, and complex chronic markets where claims alone miss important journey detail.
• Less ideal fit: A fixed syndicated dashboard, single disease registry, managed hub program, media-buying agency, or outsourced analytics service may be simpler when source-level data selection and linkage are not central to the work.
• Commercial fit: Subscription and enterprise data-access models are likely; scope should define included sources, permitted uses, refresh cadence, delivery format, and user roles.
• SOW diligence: Confirm source rights, patient-overlap evidence, match rates, data lag, refresh schedules, activation permissions, Symphony integration maturity, and how AI-assisted outputs are reviewed.

Differentiators

• Neutral linkage layer: HealthVerity can sit between multiple source owners, which helps buyers assemble patient journeys that are broader than any one dataset.
• Marketplace buying workflow: The Marketplace positioning now emphasizes cohort search, source transparency, single contracting, by-project or subscription access, and data delivery.
• HVID identity resolution: The HVID layer is the main reason to evaluate HealthVerity when cross-source patient linkage is the hard part of the project.
• Commercial activation extension: HealthVerity Audiences moves the platform closer to omnichannel segment activation, but buyers should validate use rights, activation partners, and campaign-measurement proof.
• Medeloop-powered evidence workflow: eXOs points to faster cohort, epidemiology, comparative-effectiveness, adherence, and time-to-event analyses; buyers should validate transparency, reproducibility, and review controls.
• Clinical-plus-commercial expansion: Symphony Health brings additional commercial analytics and prescription-market context into the HealthVerity footprint.

RFP Questions

• Which sources are included in the base contract, and which require separate licensing or use-case approvals?
• What match-rate evidence can HealthVerity provide for the exact source mix and patient cohort under review?
• What are the refresh cadences and expected data lags for claims, EHR, labs, notes, imaging, commercial, and specialty sources?
• How will linked data be delivered into the manufacturer’s cloud, warehouse, analytics tools, or agency workflow?
• How are HVID linkage, de-identification, permissible use, audit logs, and downstream restrictions documented?
• Which Audiences segments are prebuilt versus custom, and which activation partners, channels, and measurement use cases are in scope?
• What parts of Symphony Health are already integrated into the combined offering, and what remains on a transition roadmap?
• For AI-enabled analyses, what cohort logic, code, assumptions, and validation outputs are available for reviewer inspection?

Recent Activity

• May 2026: HealthVerity announced an agreement to acquire Symphony Health, combining clinical data depth with commercial analytics and services.
• May 2026: Arcadia entered the HealthVerity Marketplace with EHR-derived longitudinal data and clinical notes for life sciences use cases.
• April 2026: Thermo Fisher Scientific’s PPD clinical research business announced enterprise-level access to HealthVerity taXonomy claims data for RWD, trial feasibility, recruitment, and evidence generation work.
• October 2025: HealthVerity and Claritas Rx announced a collaboration combining HealthVerity RWD with specialty pharmacy, hub, and copay program data.
• September 2025: HealthVerity launched eXOs, a Medeloop-powered evidence studio for AI-assisted RWE and commercial analyses.
• April 2025: Recursion licensed HealthVerity real-world data for clinical trial design and analytics within Recursion OS.